LWA
BIIB icon

Lineweaver Wealth Advisors’s Biogen BIIB Stock Holding History

Lineweaver Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,338
Closed -$763K – 171
2025
Q4 		$763K Buy
4,338
+2,129
+96% +$348K 0.1% 122
2025
Q3 		$309K Buy
+2,209
New +$299K 0.05% 146

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lineweaver Wealth Advisors's BIIB Position: Q1 2026 in Review

Lineweaver Wealth Advisors sold out of Biogen (BIIB) in Q1 2026, closing a stake of 4,338 shares — an estimated $763K sold.

Lineweaver Wealth Advisors first reported a position in BIIB in Q3 2025 and held it in 2 quarters. The position peaked at $763K in Q4 2025. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Lineweaver Wealth Advisors reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Lineweaver Wealth Advisors sold 4,338 Biogen shares in Q1 2026, an estimated $763K.
  • Lineweaver Wealth Advisors first reported a position in Biogen in Q3 2025 and held it in 2 quarters.
  • Lineweaver Wealth Advisors's Biogen position peaked at $763K in Q4 2025.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.